Hoechst AG

What Hoechst AG does

Hoechst GmbH is a German Gesellschaft mit beschränkter Haftung (GmbH) registered in Frankfurt am Main that functions exclusively as a holding company for participations in companies of the Sanofi group. Headquartered at Industriepark Hoechst, Gebäude K703, D-65926 Frankfurt am Main, the entity is registered under HRB 75707 at the Commercial Register of Frankfurt am Main and is wholly owned by Sanofi. The company offers no commercial products or services; pricing is not applicable. Its sole operating function is holding equity participations in other Sanofi group entities, and inquiries to the entity relate only to corporate history and historical archive materials.

The entity traces its lineage to Hoechst AG, historically a major German pharmaceutical and chemical company. In 1999, Hoechst AG merged with the French company Rhône-Poulenc to form Aventis, one of the five major cross-border mergers that reshaped European industry in the 1980s and 1990s. Following Sanofi's 2004 acquisition of Aventis, Hoechst Aktiengesellschaft was converted into Hoechst GmbH and restructured as a holding entity within Sanofi. In 2009, the former HistoCom GmbH — the entity responsible for industrial archiving and historical services — was dissolved, and the Hoechst corporate archive was transferred to Hoechst GmbH, which now fields historical and archival inquiries at [email protected].

Hoechst GmbH is governed by Managing Directors (Geschäftsführer) Heidrun Irschik-Hadjieff and Marcus Lueger, with Brendan O'Callaghan serving as Chairman of the Supervisory Board (Vorsitzender des Aufsichtsrats). Operating geographies are limited to DACH/Germany, no global footprint is claimed, and the entity has no independent external investor base, no funding rounds, no disclosed headcount, and no subsidiaries of its own. As a structurally non-operating entity, Hoechst GmbH is not a commercial enterprise and generates no standalone revenue.

Name

Hoechst AG

Legal name

Hoechst GmbH

Website

https://hoechst.de

Company type

Private

Founded year

1999

Operating status

Operating

Short description

Hoechst GmbH is a Frankfurt am Main-based holding company that holds participations in companies of the Sanofi group. It is wholly owned by Sanofi, offers no commercial products or services, and historically traces back to Hoechst AG prior to the 1999 merger with Rhône-Poulenc.

Ownership category

akta.pro rank

Headquarters

HQ city

Frankfurt

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others

Core offering

Hoechst GmbH functions as a holding company within the Sanofi group, managing equity participations in Sanofi group companies. The entity maintains the historical company archive of the former Hoechst AG (including industrial archiving and historical services previously performed by HistoCom GmbH, which was dissolved in 2009). It does not develop, manufacture, or sell commercial products or services directly to external customers.

Product overview

Hoechst GmbH is a holding company within the Sanofi Group, managing participations in Sanofi group companies. The entity no longer operates as an independent pharmaceutical manufacturer following the 1999 merger with Rhône-Poulenc to form Aventis, which was subsequently acquired by Sanofi. The source material does not contain specific product listings for Hoechst-branded offerings.

Differentiator

Problem solved

Functional benefit

Products and services

• Hoechst Corporate Archive Services Historical and industrial archival services transferred from the dissolved HistoCom GmbH in 2009, providing access to historical records of the former Hoechst AG for corporate, historical, and research inquiries. Inquiries are submitted in writing via email.

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Rhône-PoulencflagshipStrategic or Co-development PartnerHoechst AG merged with Rhône-Poulenc in 1999 to form Aventis, creating one of the largest pharmaceutical companies in Europe. This major cross-border merger combined complementary capabilities of both companies and was one of the defining consolidation events in European pharmaceutical industry history.

Scale indicators1 record

Recent moves6 records

Expansion highlights1 record

Direct peers

• Sanofi-Aventis Deutschland GmbH: Direct sister subsidiary within the Sanofi group operating in Germany. Functions as the principal operating Sanofi entity in Germany and shares Hoechst GmbH's structural role within the same corporate group.

Broad incumbents

• Bayer AG: Major German pharmaceutical and chemical company with industrial heritage directly comparable to Hoechst AG's origins. Operates actively in pharmaceuticals, crop science, and consumer health.
• BASF SE: Largest German chemical company and historical contemporary of Hoechst AG's chemical operations. Closest German chemical incumbent by scale and historical positioning.
• Merck KGaA: German pharmaceutical and life science company with diversification comparable to Hoechst AG's historical scope across healthcare, life sciences, and performance materials.
• Evonik Industries AG: German specialty chemicals company with industrial heritage in Germany. Comparable to Hoechst AG's chemical operations as another legacy German chemical enterprise.
• Boehringer Ingelheim: Major German pharmaceutical company headquartered in Ingelheim, comparable as a large privately-held German pharma enterprise with deep industrial heritage.
• Fresenius SE & Co. KGaA: German healthcare group with diversified operations across pharmaceuticals, hospital care, and medical devices. Comparable as a large diversified German healthcare enterprise with similar industrial age roots.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/hoechst-ag

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hoechst AG